SCHEMBL14525642

SCHEMBL14525642

CC(=O)[C@H]1CC[C@@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@H]3C(=O)C[C@]12C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SERPINA6 P08185 3/20 1.00
▸ CYP3A4 P08684 6/20 0.72
▸ SMN1; SMN2 Q16637 6/20 0.72
▸ LMNA P02545 5/20 0.72
▸ ALDH1A1 P00352 5/20 0.72
▸ TSHR P16473 3/20 0.72
▸ NR3C2 P08235 3/20 0.72
▸ CYP2C9 P11712 2/20 0.72
▸ HIF1A Q16665 2/20 0.72
▸ MAPT P10636 2/20 0.72
▸ MAPK1 P28482 2/20 0.72
▸ NR3C1 P04150 2/20 0.72
▸ SHBG P04278 2/20 0.72
▸ PMP22 Q01453 2/20 0.72
▸ CYP2C19 P33261 1/20 0.72
▸ KDM4E B2RXH2 1/20 0.72
▸ MEN1 O00255 1/20 0.72
▸ SLC22A2 O15244 1/20 0.72
▸ SLC22A1 O15245 1/20 0.72
▸ NR1I2 O75469 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15920543 1.00 SERPINA6 (1.00) SERPINA6CYP3A4SMN1; SMN2LMNAALDH1A1
SCHEMBL14420894 1.00 SERPINA6 (1.00) SERPINA6CYP3A4SMN1; SMN2LMNAALDH1A1
SCHEMBL668966 1.00 SERPINA6 (1.00) SERPINA6CYP3A4SMN1; SMN2LMNAALDH1A1
SCHEMBL15904593 1.00 SERPINA6 (1.00) SERPINA6CYP3A4SMN1; SMN2LMNAALDH1A1
SCHEMBL9348234 0.92 SERPINA6 (0.85) SERPINA6CYP3A4SMN1; SMN2LMNAALDH1A1
SCHEMBL18927106 0.92 SERPINA6 (0.85) SERPINA6CYP3A4SMN1; SMN2LMNAALDH1A1
SCHEMBL9348241 0.92 SERPINA6 (0.85) SERPINA6CYP3A4SMN1; SMN2LMNAALDH1A1
SCHEMBL6347180 0.91 SERPINA6 (0.84) SERPINA6CYP3A4SMN1; SMN2LMNAALDH1A1
SCHEMBL31095098 0.90 SERPINA6 (0.82) SERPINA6CYP3A4SMN1; SMN2LMNAALDH1A1
SCHEMBL5497592 0.89 SERPINA6 (0.80) SERPINA6CYP3A4SMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093460-A1 Methods of using selective 11beta-HSD inhibitors to treat gluocorticoid associated states RHODE ISLAND HOSPITAL, THE 2007-04-26 — — US disclosed
US-20070093460-A1 Methods of using selective 11beta-HSD inhibitors to treat gluocorticoid associated states RHODE ISLAND HOSPITAL, THE 2007-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093460-A1 Methods of using selective 11beta-HSD inhibitors to treat gluocorticoid associated states HSD11B2, HSD11B1, HSD17B2 SERPINA6 70/4885CYP3A4 315/4885SMN1; SMN2 2298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback